July 28 (Reuters) - CogState Ltd CGS.AX :
* Sales contract update CGS.AX
* Cogstate Technology selected for use in phase II clinical trial studying alzheimer's disease
* Says existing sales contracts will generate A$13.0 million of clinical trials revenue in FY 2016
* Says the contract value of US$1.2 million will be recognised over the life of the study
* Source text for Eikon ID:nASX2GMgf9